30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Virpax Pharmaceuticals Inc (VRPX)

Track

Stock chart
Ticker: VRPX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Sendrow Jerrold
1 purchase — total 5,805 USD
Buy 24 May 2022
Value US$3,995,743.25 | Price 425.95 | Shares 47,390
Buy 18 May 2022
Value US$2,915,130.22 | Price 323.45 | Shares 52,185
Buy 18 May 2022
Value US$101,505.00 | Price 1.34 | Shares 75,750
Buy 22 Nov 2021
Value US$15,307.50 | Price 3.93 | Shares 3,900
Buy 18 Nov 2021
Value US$100,248.75 | Price 3.99 | Shares 25,125
Buy 17 Feb 2021
Value US$716.00 | Price 7.16 | Shares 100
Buy 17 Feb 2021
Value US$23,761.50 | Price 6.79 | Shares 3,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-26 2022-05-24 B Purchase
Sendrow Jerrold
Non-Executive Director
47,390 +33.1%
425.95
US$3,995,743 		47,390 +33.1% 425.95 US$3,995,743
2022-05-20 2022-05-18 B Purchase
Floyd Eric
Non-Executive Director
52,185 +1.2%
323.45
US$2,915,130 		52,185 +1.2% 323.45 US$2,915,130
2022-05-20 2022-05-18 B Purchase
Mack Anthony P.

Chief Executive Officer

Executive Director
77,395 -25.6%
285.84
US$677,400 		77,395 -25.6% 285.84 US$677,400
2021-11-24 2021-11-22 B Purchase
Sendrow Jerrold
Non-Executive Director
3,900 +643.6%
3.93
US$15,308 		3,900 +643.6% 3.93 US$15,308
2021-11-22 2021-11-18 B Purchase
Mack Anthony P.

Chief Executive Officer

Executive Director Large shareholder
25,125 +16.6%
3.99
US$100,249 		25,125 +16.6% 3.99 US$100,249
2021-03-01 2021-02-17 B Purchase
Jambulingam Thani
Non-Executive Director
100 +inf%
7.16
US$716 		100 +inf% 7.16 US$716
2021-02-19 2021-02-17 B Purchase
3.6
JACOB GARY S
Non-Executive Director
3,500 +inf%
6.79
US$23,762 		3,500 +inf% 6.79 US$23,762
Explore more

More insider trading research around Virpax Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America